Mareike Rasche, MD^1*, Martin Zimmermann^2*, Emma Steidel^1*, Todd A. Alonzo, PhD^3*, Richard Aplenc, MD, PhD⁴, Jean-Pierre Bourquin, MD, PhD⁵, Heidrun Boztug^6*, Alan S. Gamis, MD, MPH⁷, Robert B. Gerbing, MA^8*, Iveta Janotová^9*, Thomas Lehrnbecher^10*, Nora Muehlegger^6*, Nils Von Neuhoff, PhD^1*, Naghmeh Niktoreh^1*, Lucie Sramkova, MD^9*, Jan Stary, MD, PhD^9*, Christiane Walter, MSc^1*, Ursula Creutzig, MD, PhD^2*, Michael Dworzak, MD, PhD^6*, Edward A. Kolb, MD¹¹ and Dirk Reinhardt, MD¹

¹Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
²Department of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany
³University of Southern California, Los Angeles, CA
⁴Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁵Department of Pediatric Oncology, University Children's Hospital Zurich, Zurich, Switzerland
⁶St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
⁷Hematology/Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO
⁸Children's Oncology Group, Monrovia, CA
⁹Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
¹⁰Division for Pediatric Hematology and Oncology, University of Frankfurt, Frankfurt, DEU
¹¹Nemours/Alfred I. Dupont Hospital for Children, Wilmington, DE

Pilar Martínez, MD^1*, Tomás Palanques Pastor^2*, Jose Luiz Lopez Lorenzo, MD^3*, Javier Cornago Navascués, MD^4*, Gabriela Rodriguez-Macías, MD^5*, Isabel Cano, MD^6*, Montserrat Arnan Sangerman, MD, PhD^7*, María-Belén Vidriales, MD, PhD^8*, Jesús Lorenzo Algarra^9*, Maria Angeles Foncillas^10*, Pilar Herrera Puente^11*, Carmen Botella^12*, Susana Vives, MD^13*, Angela Figuera Alvarez, MD, PhD^14*, Laida Cuevas Palomares^15*, Marta Sobas, MD PhD^16*, Alejandro Contento-Gonzalo, MD^17*, Rebeca Cuello, MD^18*, María Elena Amutio Diez, MD^19*, Maria Dunia De Miguel, MD^20*, Begoña Navas, MD^21*, Juan Miguel Bergua Burgues, MD^22*, Teresa Bernal del Castillo, MD, PhD^23*, María Carmen Mateos Rodríguez, MD^24*, Erik de Cabo López, MD^25*, Ana Carolina Franco Villegas, MD^26*, Raimundo García-Boyero, MD^27*, Cristian Escolano Escobar, MD^28*, Cristina Seri, MD^29*, Carlos Cervero, MD^30*, Alicia Roldán Pérez^31*, Maria Lourdes Hermosin, MD^32*, Marta Cervera, MD^33*, María Teresa Olave, MD^34*, Paola Sandra Villafuerte Gutierrez, MD^35*, Almudena De Laiglesia, MD^36*, Josefina Serrano, MD^37*, María Josefa Najera Irazu, MD^38*, Jose Luis Piñana Sanchez^39*, Miguel Ángel Sanz, MD³⁹, Joaquin Martinez-Lopez, MD^40* and Pau Montesinos, MD, PhD^41*

¹Hematology Department, Hospital Universitario 12 de Octubre,, Madrid, Spain
²Pharmacy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
³Servicio de Hematología y Hemoterapia, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
⁴Hematology and hemotherapy department, Hospital Universitario Fundación Jiménez Díaz, Valencia, Spain
⁵Hematology and hemotherapy department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁶Hospital Universitario y Politécnico La Fe, Valencia, Spain
⁷Clinic hematology department, Instituto Catalán de Oncología, Hospitalet del Llobregat, Spain
⁸Hematology department, Hospital Universitario de Salamanca, Salamanca, Salamanca, Spain
⁹Hematology department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
¹⁰Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
¹¹Hematology department, Hospital Ramón y Cajal, Madrid, Spain
¹²Hematology department, Hospital General Universitario de Alicante, Alicante, Spain
¹³Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
¹⁴Hematology and hemotherapy department, Hospital Universitario de la Princesa, Madrid, Spain
¹⁵Hematology and hemotherapy department, Hospital Txagorritxu, Vitoria, Spain
¹⁶Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
¹⁷Hematology and hemotherapy department, Hospital Regional Universitario de Málaga, Málaga, Spain
¹⁸Hematology and hemotherapy department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
¹⁹Hematology and hemotherapy department, Hospital Universitario de Cruces, Barakaldo, Spain
²⁰Hematology department, Hospital Universitario de Guadalajara, Guadalajara, Spain
²¹Hematology and hemotherapy department, Hospital Universitario HLA Moncloa, Madrid, Spain
²²Hematology and hemotherapy department, Hospital San Pedro de Alcántara, Cáceres, Spain
²³Hospital Universitario Central Asturias, ISPA, IUOPA, Oviedo, Spain
²⁴Hematology department, Complejo Hospitalario de Navarra, Pamplona, Spain
²⁵Hematology and hemotherapy department, Hospital El Bierzo, Ponferrada, Spain
²⁶Oncology and clinic hematology department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain
²⁷Hematology and hemotherapy department, Hospital Universitario General de Castellón, Castellón de la Plana, Spain
²⁸Hematology and hemotherapy department, Hospital Universitario de Getafe, Getafe, Spain
²⁹Hematology and hemotherapy department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain
³⁰Hematology department, Hospital Virgen de la Luz, Cuenca, Spain
³¹Hematology and hemotherapy department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain
³²Jerez de la Frontera Hospital, JEREZ DE LA FRONTERA, Spain
³³ICO-Hospital Joan XXIII, Tarragona, Spain
³⁴Hematology and hemotherapy department, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain
³⁵Hematology and hemotherapy department, Hospital Universitario Príncipe de Asturias, Alcala De Henares, Spain
³⁶Hematology and hemotherapy department, Hospital Universitario Puerta De Hierro, Majadahonda, Spain
³⁷Clinical Hematology, Hospital Universitario Reina Sofía, Córdoba, Spain
³⁸Hematology department, Hospital San Pedro, Logroño, Spain
³⁹Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁴⁰Hematology and hemotherapy department, Hospital Universitario 12 De Octubre, Madrid, Spain
⁴¹Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain

David M Swoboda, MD¹, Najla E. Al Ali², Eric Padron, MD³, Andrew T. Kuykendall, MD³, Jinming Song, MD, PhD^4*, Mohammad O Hussaini, MD^5*, Jeffrey E. Lancet, MD³, Kendra L. Sweet, MD, MS^3*, David A. Sallman, MD³ and Rami Komrokji, MD⁶

¹Department of Hematology and Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Department of Hematopathology and Lab Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Department of Hematopathology and Lab Medicine, Moffitt Cancer Center, Tampa, FL
⁶Moffitt Cancer Center, Tampa, FL

Michael Luebbert, MD, PhD^1,2, Olga Grishina^3*, Claudia Schmoor^3*, Martina Crysandt^4*, Edgar Jost^4*, Felicitas Thol⁵, Michael Heuser⁵, Katharina S. Götze^6,7, Richard F. Schlenk^8,9,10, Konstanze Dohner, MD⁸, Helmut R. Salih¹¹, Marcus M. Schittenhelm^12*, Gerhard Heil^13*, Carsten Schwaenen^14,15*, Carsten Mueller-Tidow, MD^9,16,17*, Wolfram Brugger¹⁸, Andrea Kündgen^19,20*, Ulrich Germing^19,20*, Maike de Wit^21*, Stephan Kremers^22*, Aristoteles Giagounidis^23*, Sebastian Scholl^24*, Andreas Neubauer, Professor Dr²⁵, Jürgen Krauter, MD^26*, Gesine Bug^27,28*, Ralph Wäsch¹, Heiko Becker^1,2, Christoph Rummelt^1*, Annette M. May^29*, Justus Duyster^1,2*, Arnold Ganser⁵, Björn Hackanson^1,30* and Hartmut Döhner⁸

¹Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Freiburg, Freiburg, Germany
³Clinical Trials Unit, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁴Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, University Hospital Aachen, Aachen, Germany
⁵Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁶Department of Medicine III, Technical University of Munich, Munich, Germany
⁷German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, München, Germany
⁸Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁹Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
¹⁰National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center, Heidelberg, Germany
¹¹Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen, Germany
¹²Clinic for Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
¹³Department of Hematology/Oncology, Klinikum Luedenscheid, Luedenscheid, Germany
¹⁴Department of Medical Oncology, Ortenau Hospital Offenburg, Offenburg, Germany
¹⁵Department of Internal Medicine, Oncology, Hematology, Gastroenterology and Infectious Diseases, Hospital Esslingen, Esslingen, Germany
¹⁶German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany
¹⁷Department of Medicine A, University Hospital of Münster, Münster, Germany
¹⁸Department of Hematology, Hospital Villingen-Schwenningen, Villingen-Schwenningen,, Germany
¹⁹Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Faculty of Medicine, Düsseldorf, Germany
²⁰German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Düsseldorf, Düsseldorf, Germany
²¹Department of Hematology and Oncology, Vivantes Klinikum Neukölln, Berlin, Germany
²²Caritaskrankenhaus Lebach, Lebach, DEU
²³Clinic for Oncology, Hematology and Palliative Medicine, Marien-Hospital Düsseldorf, Düsseldorf, DEU
²⁴Department of Hematology and Oncology, Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany
²⁵Department of Hematology and Oncology, University Clinic Gießen/Marburg, Marburg, Germany
²⁶Department of Internal Medicine III, Städtisches Klinikum Braunschweig, Braunschweig, Germany
²⁷Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany
²⁸German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Frankfurt, Frankfurt, Germany
²⁹Institute for Surgical Pathology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
³⁰Department of Internal Medicine, Universitätsklinikum Augsburg, Augsburg, Germany

Shannon E. Conneely, MD, Casey L. McAtee, MD^* and Rachel E. Rau, MD

Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Amer M. Zeidan, MBBS, MHS¹, Prajwal Boddu, MD², Brent L Wood, MD, PhD³, Daniel Zelterman^4*, Richard F. Little, MD, MPH⁵, S. Percy Ivy, MD^6*, Anne Caldwell^7*, Beatriz Sanchez-Espiridion^8*, Gheath Alatrash⁹, Elad Sharon, MD, MPH^10* and Jerald P. Radich, MD¹¹

¹Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²Hematology, Yale New Haven Hospital, New Haven, CT
³Department of Laboratory Medicine,, University of Washington, Seattle, WA
⁴Yale School of Public Health, New Haven, CT
⁵National Cancer Institute, Washington, DC
⁶National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
⁷Yale cancer center, Yale University, new haven, CT
⁸MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
¹¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Jurjen Versluis^1*, Yael Flamand, MS^2*, Erika J. Haydu, MD, PhD^3*, Rahul S. Vedula, MD³, Anne Charles, BS^3*, Kevin Copson, MA^3*, Ofir Wolach, MD^4*, Pavan Bendapudi, MD⁵, Roger Belizaire, MD, PhD⁶, Donna S. Neuberg, ScD², Marlise R Luskin, MD, MS⁷ and R. Coleman Lindsley, MD, PhD³

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Jamaica Plain, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
⁵Division of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA
⁶Department of Pathology, Division of Transfusion Medicine, Brigham and Women's Hospital, Boston, MA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston

Ghayas C. Issa, MD¹, Jabra Zarka, MD^1*, Koji Sasaki, MD¹, Daewoo Pak, PhD^2*, Jing Ning, PhD^2*, Nicholas J. Short, MD¹, Elias Jabbour, MD¹, Tapan M. Kadia, MD³, Gautam Borthakur, MD³, Guillermo Garcia-Manero, MD³, Michael Andreeff, MD, PhD⁴, Hagop M. Kantarjian, MD⁵ and Farhad Ravandi, MBBS¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX

Ana Garrido, MD^1*, Montserrat Hoyos^1*, Marina Diaz-Beyá, MD^2*, Montserrat Arnan, MD^3*, Susana Vives, MD^4*, Marisa Calabuig, MD^5*, Olga Salamero, MD^6*, David Gallardo, MD^7*, Maria Paz Queipo De Llano, MD^8*, Lourdes Escoda, MD^9*, Antonia Sampol, MD¹⁰, Ferran Vall-Llovera, MD^11*, Antonio Garcia-Guiñon, MD^12*, Merchan Brayan, MD^13*, Joan Bargay, MD^14*, J Pio Torres^15*, Xavier Ortin^16*, M Luz Amigo^17*, Jose Maria Moraleda, MD, PhD^18*, José F. Falantes^19*, David Valcarcel²⁰, Mar Tormo, MD⁵, Josep-Maria Ribera²¹, Salut Brunet, MD^1*, Anna Sureda Balari, MD, PhD^22*, Jordi Esteve, MD, PhD²³ and Jorge Sierra, MD¹

¹Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²Hospital Clinic de Barcelona, Barcelona, Spain
³Hematology Department, ICO - Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
⁴Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
⁵Hospital Clínico Universitario de Valencia, Valencia, Spain
⁶Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
⁷Hematology Department, ICO - Hospital Doctor Josep Trueta, Girona, Spain
⁸Hospital Universitario Virgen de la Victoria, Málaga, Spain
⁹Hematology Department, ICO - Hospital Joan XXIII, Tarragona, Spain
¹⁰Department of Hematology, Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, Spain
¹¹Hematology Department, Hospital Mutua de Terrassa, Terrassa, Spain
¹²Hematology Department, Hospital Arnau de Vilanova, Lleida, Spain
¹³Hospital del Mar, Barcelona, Spain
¹⁴Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
¹⁵Hospital Juan Canalejo, A Coruñá, Spain
¹⁶Hospital Verge de la Cinta, Tortosa, Spain
¹⁷Hospital General de Murcia, Murcia, Spain
¹⁸Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain, Murcia, Spain
¹⁹Hospital Universitario Virgen del Rocío, Sevilla, Spain
²⁰Hospital Universitari Vall d'Hebron, Barcelona, Spain
²¹ICO-Hospital Germans Trias i Pujol, Badalona, Spain
²²Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
²³Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain

Timothy S. Pardee, MD, PhD¹, Jessica Oschwald^2*, Esprit Ma^3*, Tao Xu^4*, Melissa Montez^3*, Giridharan Ramsingh^3*, Wan-Jen Hong, MD³, Michelle Choi^5* and Evelyn M. Flahavan^6*

¹Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston Salem, NC
²Roche Products Limited, Welwyn Garden City, United Kingdom
³Genentech, Inc., South San Francisco, CA
⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁵AbbVie Inc., North Chicago, IL
⁶Roche Products Ltd, Welwyn Garden City, United Kingdom

Pau Montesinos, MD, PhD^1,2*, Christian Recher, MD, PhD^3,4, Ewa Zarzycka, MD^5*, Vadim Doronin, MD, PhD^6*, Derek McCulloch, MB, ChB, PhD^7*, Susana Vives, MD^8*, Rodrigo T. Calado, MD, PhD⁹, Jun-Ho Jang, MD^10*, Yasushi Miyazaki, MD, PhD¹¹, Jianxiang Wang, MD¹², Diego A. Gianolio, PhD^13*, Scott R. Daigle, MSc^13*, Thomas Winkler, MD^13*, Vickie Zhang, PhD^13* and Peter Paschka, MD¹⁴

¹Hospital Universitari i Politècnic La Fe, Valencia; CIBERONC, Instituto Carlos III, Madrid, Spain
²Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
³Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Toulouse, France
⁴Université de Toulouse III, Toulouse, France
⁵Klinika Hematologii i Transplantologii, Uniwersyteckie Centrum Kliniczne, Gdansk, Poland
⁶City Clinical Hospital #40, St. Petersburg, Russian Federation
⁷Royal Prince Alfred Hospital, Camperdown, Australia
⁸Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
⁹University of Sao Paulo, Ribeirão Preto, SP, Brazil
¹⁰Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹¹Atomic Bomb Disease Institute, Nagasaki University Hospital, Nagasaki, Japan
¹²National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
¹³Agios Pharmaceuticals, Inc., Cambridge, MA
¹⁴University Hospital Ulm, Ulm, Germany

Bethany Lockwood, MD^1*, Areej El-Jawahri, MD², Alison R. Walker, MD³, Deborah Russell, FNP-BC, ACHPN^1*, Jillian Gustin, MD^1*, Sarah Ehrman, MD^1*, Seuli Bose-Brill, MD^4*, Maryam Lustberg, MD^5* and Bhavana Bhatnagar, DO³

¹Palliative Medicine, The Ohio State University, Columbus, OH
²Massachusetts General Hospital / Harvard Medical School, Allston, MA
³Hematology, The Ohio State University, Columbus, OH
⁴General Internal Medicine & Pediatrics, The Ohio State University, Columbus, OH
⁵Medical Oncology, The Ohio State University, Columbus, OH

Daijing Nie, MD^1*, Fang Wang, MD¹, Jing Zhang^2*, Xvxin Li^1*, Lili Liu^3*, Wei Zhang^3*, Panxiang Cao, MS^1*, Xue Chen, MD^4*, Yang Zhang, MD⁵, Jiaqi Chen, MD^1*, Xiaosu Zhou, PhD^6*, Qisheng Wu^3* and Hongxing Liu, MD^1,6,7

¹Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
²Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, CHN
³Hebei Yanda Lu Daopei Hospital, Langfang, CHN
⁴Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Beijing, China
⁵Beijing Lu Daopei Hospital, Beijing, Her Bei Province, China
⁶Beijing Lu Daopei Institute of Hematology, Beijing, China
⁷Division of Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China

Geoffrey L Uy, MD¹, Michael P. Rettig, PhD², Stephanie Christ, MS^3*, Ibrahim Aldoss, MD⁴, Michael T. Byrne, DO⁵, Harry P. Erba, MD, PhD⁶, Martha L. Arellano, MD⁷, Matthew C Foster, MD⁸, John E. Godwin, MD⁹, Farhad Ravandi, MBBS¹⁰, Peter H. Sayre, MD, PhD¹¹, Anjali S Advani, MD¹², Matthew J. Wieduwilt, MD, PhD¹³, Ashkan Emadi, M.D., Ph.D.¹⁴, Laura C. Michaelis, MD¹⁵, Patrick J. Stiff, MD¹⁶, Martin Wermke^17*, Norbert Vey, MD¹⁸, Patrice Chevalier, MD, PhD^19*, Emmanuel Gyan, MD, PhD²⁰, Christian Recher, MD, PhD²¹, Fabio Ciceri, MD^22*, Matteo Giovanni Carrabba, MD^23*, Antonio Curti, MD PhD²⁴, Geert Huls, MD, PhD²⁵, Max S. Topp, MD²⁶, Mojca Jongen-Lavrencic, MD, PhD²⁷, John Muth, MS^28*, Teia Curtis^29*, Mary Beth Collins^30*, Erin Timmeny^31*, Kuo Guo, MSc^32*, Jian Zhao, PhD^32*, Kathy Tran^28*, Patrick Kaminker, PhD^33*, Priyanka Patel, PharmD^30*, Ouiam Bakkacha, MD^34*, Kenneth Jacobs, MD^35*, Maya Kostova, PhD^32*, Jennifer Seiler, PhD, RAC^30*, Bob Lowenberg, MD, PhD³⁶, Sergio Rutella, MD, PhD, FRCPath³⁷, Roland B. Walter, MD, PhD, MS³⁸, Ezio Bonvini, MD³³, Jan K Davidson-Moncada, MD, PhD³⁹ and John F. DiPersio, MD¹

¹Washington University School of Medicine, Saint Louis, MO
²Department of Internal Medicine, Division of Oncology, Washington Univ. School of Med., Saint Louis, MO
³Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
⁵Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
⁶University of Alabama at Birmingham, Birmingham, AL
⁷Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁸Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, Chapel Hill, NC
⁹Providence Portland Medical Center, Portland, OR
¹⁰Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
¹¹University of California, San Francisco, San Francisco, CA
¹²Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
¹³Moores Cancer Center, University of California, San Diego, La Jolla, CA
¹⁴University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹⁵Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
¹⁶Loyola University Chicago Stritch School of Medicine, Maywood, IL
¹⁷NCT/UCC Early Clinical Trial Unit, University Hospital Carl Gustav Carus, Dresden, Germany
¹⁸Hematologie clinique, Institut Paoli Clamettes, Marseille, France
¹⁹Department of Hematology and Cell Therapy, CHU Nantes, Nantes, France
²⁰CHU de Tours - Hôpital Bretonneau, Tours, France
²¹Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
²²Haematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
²³Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
²⁴Hematology/Oncology "L. e A. Seràgnoli", Sant’Orsola-Malpighi University Hospital, Bologna, Bologna, Italy
²⁵Department of Hematology, University Medical Center Groningen, Groningen, GZ, Netherlands
²⁶Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
²⁷Erasmus University Medical Center, Rotterdam, Netherlands
²⁸MacroGenics, Inc., Rockville, MD
²⁹MacroGenics, Inc., Frederick, MD
³⁰MacroGenics, Rockville
³¹MacroGenics, Inc., ROCKVILLE, MD
³²MacroGenics, Rockville, MD
³³Macrogenics, Rockville, MD
³⁴Macrogenics,Inc, ROCKVILLE, MD
³⁵MacroGenics, Inc, Rockville, MD
³⁶Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
³⁷John van Geest Cancer Centre School of Science and Technology, Nottingham Trent University, Nottingham, ENG, United Kingdom
³⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³⁹MacroGenics, Inc., Washington, DC

Beth A Pitel, MS^1*, Neeraj Sharma, PhD^2*, Cinthya Zepeda-Mendoza, PhD^3*, James B Smadbeck, PhD^4*, Kathryn E. Pearce, MS^1*, Stephanie A. Smoley, BA^1*, Joselle Cook, MBBS⁵, George Vasmatzis, PhD^6*, Zohar Sachs, MD, PhD^7,8, David S. Viswanatha, MD¹, Robert Jenkins, MD, PhD^1*, Xinjie Xu, PhD¹, Sheng Xiao, MD^9*, Nicole Hoppman, PhD¹, Rhett P. Ketterling, MD^1*, Jess Peterson, MD¹, Patricia Greipp, DO¹ and Linda B Baughn, PhD¹

¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³ARUP Laboratories, Salt Lake City, UT
⁴Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Center for Individualized Medicine, Biomarker Discovery, Mayo Clinic, Rochester, MN
⁷Masonic Cancer Center, University of Minnesota, Minneapolis, MN
⁸Department of Medicine, Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁹Dana Farber, Harvard Cancer Center, Brigham And Women's Hospital, Boston, MA

Clara Chen^1*, Tim Disher^2*, Muhaimen Siddiqui^2*, Ignazia La Torre^1*, Barry Skikne, MD^1,3*, Beatrice Suero^2*, Heather Cameron^2*, Roya Gavanji^2* and Chris Cameron^2*

¹Bristol Myers Squibb, Princeton, NJ
²EVERSANA, Burlington, ON, Canada
³Kansas University Medical Center, Kansas City, KS

Michael Castro, MD^1*, Prashant Ramachandran Nair, B.Tech.^2*, Himanshu Grover, M.S.^2*, Ansu Kumar, M.Sc.^2*, Ashish Agarwal, B.V.Sc.^2*, Rakhi Purushothaman Suseela, B.Tech.^2*, Reshma P Gopi, M.Sc.^2*, Naga Ganesh, B.Tech.^2*, Vijayashree P Shyamasundar, M.Sc.^2*, Shruthi Kulkarni, B.E.^2*, Mohammed Sauban, B.E.^2*, Ashokraja Balla, M.Tech.^2*, Srushti P Chafekar, M.Sc.^2*, Sayantani Roy Choudhury, M.Sc.^2*, Nirjhar Mundkur^3*, Michele Dundas Macpherson, B.A.Sc.^4*, Shweta Kapoor, M.Sc.^2* and Scott Howard, MD⁵

¹Personalized Cancer Medicine, PLLC, Los Angeles, CA
²Cellworks Research India Private Limited, Bangalore, India
³Cellworks Group Inc., San Jose, CA
⁴Cellworks Group Inc., South San Francisco, CA
⁵University of Tennessee Health Science Center, Memphis, TN

Meiwei Gong^1*, Hui Wang, MD^2*, Aixian Wang^1*, Xueying Wu^3*, Junyi Zhen^1*, Man Chen^1*, Qing Du^1* and Peihua Lu, MD⁴

¹Pathology & Laboratory Medicine Division, Hebei Yanda Ludaopei hospital, Langfang, China
²Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Beijing, Beijing, China
³Pathology & Laboratory Medicine Division, Hebei Yanda Ludaopei Hospital, Langfang, China
⁴Hebei Yanda Lu Daopei Hospital, Langfang, China

Hussein A Abbas, MD, PhD¹, Patrick K Reville, MD², Alexis Geppner^3*, Maro Ohanian, DO^4*, Koji Sasaki, MD⁵, Gautam Borthakur, MD⁴, Naval Daver, MD⁶, Courtney D. DiNardo, MD, MSc⁷, Carlos E. Bueso-Ramos, MD, PhD⁸, Michael Andreeff, MD, PhD⁹, Nicholas J. Short, MD⁴, Sherry A. Pierce, BSN, BA^4*, Elias Jabbour, MD⁴, Guillermo Garcia-Manero, MD⁴, Marina Konopleva, MD, PhD¹⁰, Farhad Ravandi, MBBS¹¹, Hagop M. Kantarjian, MD¹² and Tapan M. Kadia, MD¹³

¹Division of Cancer Medicine, Medical Oncology Fellowship, UT M. D. Anderson Cancer Center, Houston, TX
²Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³UT M. D. Anderson Cancer Center, Houston
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
¹²University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX

Binav Baral, MD^1*, Hafeez Shaka, M.D^1*, Trilok Shrivastava, MD^2*, Shristi Upadhyay Banskota, MD^1*, Andres E Mendez-Hernandez, MD³ and Maryam Zia⁴

¹John H Stroger Hospital of Cook County, Chicago, IL
²John H Stroger Jr. Hospital of Cook County, Chicago, IL
³UNM Cancer Center, University of New Mexico, Albuquerque, NM
⁴Division of Hematology/Oncology, John H Stroger Jr. Hospital of Cook County, Chicago, IL

Ofir Wolach, MD^1,2*, Itai Levi, MD^3*, Jonathan Canaani, MD⁴, Tamar Tadmor, MD^5,6*, Sigal Tavor, MD^7*, Ilana Hellmann, MD^8*, Tsila Zuckerman, MD^6,9, David Lavie, MD^10*, Galia Stemer, MD^11*, Raanan Cohen, MD^12*, Ran Afik, PhD^12*, Keren Ofek, PhD^12*, Hilla Banayan, BSc MBA^12*, Inna Kan, PhD^12*, Moshe Grunspan, PhD^12*, Yishai Ofran, MD^6,9 and Yakir Moshe, MD, PhD^1,13*

¹Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
³Soroka University Medical Center, Be'er-Sheva, Israel
⁴Hematology Division, Sheba Medical Center, Givatayim, Israel
⁵Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
⁶The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁷Hemato-Oncology, Assuta Medical Center, Tel Aviv, Israel
⁸Department of Hematology, Meir Medical Center, Kfar Saba, Israel
⁹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
¹⁰Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
¹¹Hematology Unit, Ha'Emek Medical Center, Afula, Israel
¹²AbbVie Inc, Hod-Hasharon, Israel
¹³Department of Hematology, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel

Rory M. Shallis, MD¹, Nikolai A. Podoltsev, MD, PhD², Thomas Prebet, MD, PhD³ and Amer M. Zeidan, MBBS, MHS⁴

¹Yale Cancer Center, West Haven, CT
²Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
³Hematology, Yale University, New Haven, CT
⁴Yale University School of Medicine and Yale Cancer Center, New Haven, CT

Amer M. Zeidan, MBBS, MHS¹, Adrienne M. Gilligan, PhD^2*, Santosh Gautam, PhD^2*, David L. Grinblatt, MD³, Dina Elsouda^4*, Loretta Sullivan, MD, MPH^4* and Bhavik J. Pandya, PharmD^4*

¹Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²ConcertAI, Memphis, TN
³NorthShore University HealthSystem, Evanston, IL
⁴Astellas Pharma Global Development, Inc., Northbrook, IL

Fumi Nakamura^*, Sachiko Seo^*, Honoka Arai^*, Yuka Nakamura^*, Tomoyuki Handa^*, Wataru Takahashi^*, Shiho Furuichi^*, Fusako Nagasawa^*, Jiro Tadokoro^*, Shigeharu Tsurumi^*, Yuko Nakamura^*, Ko Sasaki, Motoshi Ichikawa^* and Kinuko Mitani

Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan

John Welch, MD PhD^1*, Lakshmi R Chelapareddy, MD^2*, Michelle Richardson^3*, Ryo Kita, MD PhD^3*, Megan Haney^2*, Susanna Wen, PhD^3* and Hiroomi Tada, MD PhD³

¹Washington University School of Medicine, St Louis, MO
²Washington University School of Medicine, St. Louis, MO
³Notable Labs, Foster City, CA

Samer Al Hadidi, MD, MSc, FACP^1*, Rafee Talukder, MD^2* and Gustavo A. Rivero, MD^3,4

¹Department of Hematology and Oncology, Baylor College of Medicine, Houston, TX
²Section of Internal Medicine, Baylor College of Medicine, Porter, TX
³Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
⁴Dan L Duncan Comprehensive Cancer at Baylor St. Luke's Medical Center, Houston, TX

Emmanuel Gyan, MD, PhD^1,2, Arnaud Pigneux, MD, PhD^3*, Hunault-Berger Mathilde, MD, PhD^4,5*, Pierre Peterlin, MD^6,7*, Martin Carre, MD^8*, Jacques-Olivier Bay, MD, PhD^9,10, Caroline Bonmati, MD^11*, Maria Pilar Gallego Hernanz^12*, Bruno Lioure, MD^13*, Philippe Bertrand, MD, PhD^14*, Nicolas Vallet, MD^15*, David Ternant, PharmD, PhD^16*, François Darrouzain, PharmD, PhD^17*, Frederic Picou, PhD^2,18*, Marie C Bene, PharmSci, PhD^7*, Christian Recher, MD, PhD¹⁹ and Olivier Herault, MD, PhD^2,20

¹CHU de Tours - Hôpital Bretonneau, Tours, France
²CNRS ERL 7001 LNOx "Leukemic Niche & Redox Metabolism", Tours, France
³Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
⁴department of hematology, CHU Angers, Angers, ML, France
⁵CRCINA Centre Hospitalier Universitaire d'Angers, Angers, France
⁶Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
⁷CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
⁸Hematology, CHU Grenoble Alpes, La Tronche, France
⁹University of Auvergne, EA7453, CIC501, Clermont-Ferrand, France
¹⁰Service d'Hematologie Clinique et de Therapie Cellulaire, CHU, Universite d'Auvergne, EA7453, CIC501, Clermont-Ferrand, France
¹¹Service D'Hématologie, Centre Hospitalier Universitaire De Nancy, Nancy, FRA
¹²Cllinical Hematology, Poitiers University Hospital, Poitiers, France
¹³Département d'Hématologie et d'Oncologie, CHU Strasbourg, Strasbourg, FRA
¹⁴Faculté de Médecine de Tours, Laboratoire de Biostatistiques, Tours, France
¹⁵Department of Hematology and Cellular Therapy, Tours University Hospital, UMR CNRS, François Rabelais University, Tours, France
¹⁶Université FrançOis Rabelais De Tours, Tours Cedex 9, FRA
¹⁷Laboratoire de Pharmacologie-Toxicologie, Centre hospitalier universitaire de Tours, Tours, France
¹⁸CNRS UMR 7292, LNOx team, Tours, France
¹⁹Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
²⁰Service d'Hématologie Biologique, Centre Hospitalier Universitaire, Tours, France

Yasuyoshi Morita^1*, Takayuki Ikezoe, MD, PhD², Kiyoshi Ando³, Masahiro Onozawa⁴, Takahisa Yamane, MD, PhD^5*, Naoko Hosono, MD, PhD⁶, Toru Kiguchi^7*, Hiromi Iwasaki^8*, Toshihiro Miyamoto, MD, PhD⁹, Miho Kasai^10*, Saori Sugimoto^11*, Yasushi Miyazaki, MD, PhD¹², Masahiro Kizaki, MD¹³ and Koichi Akashi, MD, PhD⁹

¹Department of Hematology and Rheumatology, Kindai University Hospital, Sakai, OSA, JPN
²Department of Hematology, Fukushima Medical University Hospital, Fukushima, Japan
³Department of Hematology and Oncology, Tokai University Hospital, Tokyo, Japan
⁴Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
⁵Osaka City General Hospital, Department of Hematology, Osaka, Japan
⁶Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Japan
⁷Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan
⁸Department of Hematology, National Hospital Organization Kyushu Medical Center, FUKUOKA, JPN
⁹Department of Medicine and Biosystemic Science Faculty of Medicine, Kyushu University, Fukuoka, Japan
¹⁰Sumitomo Dainippon Pharma Oncology, Inc., Lehi, UT
¹¹Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan
¹²Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
¹³Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

Franziska Brauneck, MD^1*, Christin Ackermann, PhD^2*, Nils Wildner^2*, Jasmin Wellbrock, PhD^1*, Carsten Bokemeyer, MD^1*, Julian Schulze zur Wiesch, MD^2* and Walter Fiedler, MD¹

¹Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²Department of Medicine, Section Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany